Olanzapine Combined With Fosaprepitant, Ondansetron, and Dexamethasone for Preventing Nausea and Vomiting in Patients With Testicular Cancer

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
This study aims to investigate the efficacy and safety of olanzapine combined with fosaprepitant, ondansetron and dexamethasone compared with placebo combined with fosaprepitant, ondansetron and dexamethasone in the prevention of nausea and vomiting in germ-cell tumors receiving 5-day cisplatin chemotherapy
Epistemonikos ID: 9d6a44c632d3e8c760ab50a2430d5cf86955539c
First added on: May 10, 2024